Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD

B SEOUL, South Korea, May 7, 2026 /PRNewswire/ — Mezzion Pharma Co., Ltd. today announced written feedback from the U.S. Food and Drug Administration (FDA)…
posteditor
posteditor
Articles: 21727

Other News